Jamshidi N, Jamshidi N, Modarresi Chahardehi A, Shams E, Chaleshi V
Bioimpacts. 2025; 15:30241.
PMID: 39963557
PMC: 11830132.
DOI: 10.34172/bi.30241.
Senrung A, Lalwani S, Janjua D, Tripathi T, Kaur J, Ghuratia N
In Vitro Model. 2025; 2(6):219-248.
PMID: 39872501
PMC: 11756486.
DOI: 10.1007/s44164-023-00059-8.
Bess S, Smart G, Igoe M, Muldoon T
In Vitro Model. 2024; 3(2-3):91-108.
PMID: 39669700
PMC: 11637012.
DOI: 10.1007/s44164-024-00074-3.
Zimina T, Sitkov N, Gareev K, Mikhailova N, Combs S, Shevtsov M
Front Med (Lausanne). 2024; 11:1452298.
PMID: 39629230
PMC: 11611596.
DOI: 10.3389/fmed.2024.1452298.
Lin W, Xu Y, Hong X, Pang S
J Funct Biomater. 2023; 14(6).
PMID: 37367286
PMC: 10298934.
DOI: 10.3390/jfb14060322.
Application of Hexanoyl Glycol Chitosan as a Non-cell Adhesive Polymer in Three-Dimensional Cell Culture.
Kim D, Lee Y, Shim H, Song J, Han J, Moon K
ACS Omega. 2022; 7(22):18471-18480.
PMID: 35694497
PMC: 9178711.
DOI: 10.1021/acsomega.2c00890.
Quenching Epigenetic Drug Resistance Using Antihypoxic Microparticles in Glioblastoma Patient-Derived Chips.
Baek S, Yu S, Deng Y, Lee Y, Lee D, Kim S
Adv Healthc Mater. 2021; 11(8):e2102226.
PMID: 34963195
PMC: 11468717.
DOI: 10.1002/adhm.202102226.
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages.
Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L
Int J Mol Sci. 2021; 22(22).
PMID: 34830082
PMC: 8618305.
DOI: 10.3390/ijms222212200.
Fabrication approaches for high-throughput and biomimetic disease modeling.
Grubb M, Caliari S
Acta Biomater. 2021; 132:52-82.
PMID: 33716174
PMC: 8433272.
DOI: 10.1016/j.actbio.2021.03.006.
Rapid Evaluation of Novel Therapeutic Strategies Using a 3D Collagen-Based Tissue-Like Model.
Maury P, Porcel E, Mau A, Lux F, Tillement O, Mahou P
Front Bioeng Biotechnol. 2021; 9:574035.
PMID: 33681152
PMC: 7929985.
DOI: 10.3389/fbioe.2021.574035.
A combined 3D printing/CNC micro-milling method to fabricate a large-scale microfluidic device with the small size 3D architectures: an application for tumor spheroid production.
Behroodi E, Latifi H, Bagheri Z, Ermis E, Roshani S, Salehi Moghaddam M
Sci Rep. 2020; 10(1):22171.
PMID: 33335148
PMC: 7747638.
DOI: 10.1038/s41598-020-79015-5.
A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H, Grabos M, Becker K, Kagermeier T, Wu J, Otto M
Elife. 2020; 9.
PMID: 33138918
PMC: 7609049.
DOI: 10.7554/eLife.52904.
A cell-loss-free concave microwell array based size-controlled multi-cellular tumoroid generation for anti-cancer drug screening.
Lee S, Jeong S, Shin T, Min J, Lee D, Jeong G
PLoS One. 2019; 14(7):e0219834.
PMID: 31344058
PMC: 6658056.
DOI: 10.1371/journal.pone.0219834.
A Multiwell Microfluidic Device for Analyzing and Screening Nonhormonal Contraceptive Agents.
Li H, Garner T, Diaz F, Wong P
Small. 2019; 15(28):e1901910.
PMID: 31162807
PMC: 8996375.
DOI: 10.1002/smll.201901910.
Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
Lee J, Park D, Yang L, Kim E, Ahrberg C, Lee K
Sci Rep. 2018; 8(1):17145.
PMID: 30464248
PMC: 6249215.
DOI: 10.1038/s41598-018-35216-7.
Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors.
Fitzgerald W, Gomez-Lopez N, Erez O, Romero R, Margolis L
Am J Reprod Immunol. 2018; 80(1):e12860.
PMID: 29726582
PMC: 6021205.
DOI: 10.1111/aji.12860.
Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.
Leiva M, Ortiz R, Contreras-Caceres R, Perazzoli G, Mayevych I, Lopez-Romero J
Sci Rep. 2017; 7(1):13506.
PMID: 29044153
PMC: 5647375.
DOI: 10.1038/s41598-017-13816-z.